INDY 500 Stars Join Forces with ZERO Prostate Cancer to Put Veterans' Health in the Spotlight at Memorial Day Weekend Races

FOR IMMEDIATE RELEASE

Media Contact:
Stephanie S. Johnson
ZERO Prostate Cancer
stephjohnson@zerocancer.org | media@zerocancer.org
(202) 998-2507

INDIANAPOLIS, IN – This Memorial Day Weekend, the spotlight won’t only be on speed—it’ll be on saving lives. ZERO Prostate Cancer (ZERO), the nation’s leading advocacy and support organization for prostate cancer, is proud to announce its powerful presence across America’s most iconic motorsports stages: the Indianapolis 500 and NASCAR’s Coca-Cola 600 and BetMGM 300. The message? Veterans are twice as likely to face prostate cancer—and early detection saves lives.

In partnership with Juncos Hollinger Racing, ZERO’s logo will be featured on two cars in the 1009th Running of the Indianapolis 500—the world’s biggest single-day sporting event—on Sunday, May 25 at 12:45 PM ET (FOX). ZERO’s logo will appear on the cars of INDYCAR drivers Conor Daly and Sting Ray Robb.

At the same time, ZERO and partner AstraZeneca are making waves in NASCAR’s patriotic tribute weekend with two ZERO-branded vehicles:

• No. 66 Ford Mustang driven by Josh Bilicki in the Coca-Cola 600 (Sunday, May 25 at 6:00 PM ET on Amazon Prime)
• No. 53 Chevrolet Camaro driven by JJ Yeley in the BetMGM 300 (Saturday, May 24 at 1:00 PM ET on The CW)

Together, this high-octane campaign is bringing national visibility to a deadly disease that claims a man’s life every 15 minutes in the U.S.—and hits military Veterans at double the rate of the general population.

“This weekend isn’t just about racing—it’s about saving lives,” said Josh Bilicki. “If even one man schedules a PSA test because of this message, we’ve done our job.”

“As a 48-year-old and part of a sport deeply rooted in the Veteran community, this message really hits home,” said JJ Yeley. “We’re proud to be racing for something bigger than ourselves.”

“Prostate cancer has become too big to ignore,” said Courtney Bugler, President and CEO of ZERO Prostate Cancer. “More than 3 million men in the U.S. are living with this disease, and too many don’t even know they’re at risk—especially our Veterans. Memorial Day is about honoring those we’ve lost, and at ZERO, we’re also fighting to save the ones still here.”

This campaign aligns with ZERO’s bold initiative to save 100,000 lives by 2035, with targeted efforts toward Veterans, Black men, and rural communities—the populations most impacted by the disease.

“It’s time to race toward solutions,” said Daniele Paone, VP US, GYN/GU Cancer Franchise, AstraZeneca. “We’re proud to team up with ZERO and the motorsports community to drive awareness where it’s urgently needed.”

For nearly 30 years, ZERO has been on the front lines of the prostate cancer fight, providing education, support, and advocacy to patients and families. This Memorial Day, from Indy to Charlotte, the message is unmistakable: know your risk, talk to your doctor and get screened.

Watch the Races Live:

• BetMGM 300 (Xfinity Series): Saturday, May 24 – 1:00 PM ET on The CW
• Coca-Cola 600 (Cup Series): Sunday, May 25 – 6:00 PM ET on Amazon Prime
• Indianapolis 500 (IndyCar): Sunday, May 25 – 12:45 PM ET on FOX

Learn more and find resources at ZEROcancer.org

About ZERO Prostate Cancer

ZERO Prostate Cancer (ZERO) is on a mission to improve and save lives from prostate cancer through advocacy, education, awareness, and support. Formerly known as the National Prostate Cancer Coalition, ZERO was founded in 1996 to stand up for people impacted by prostate cancer. Today, ZERO serves as the nation's leading prostate cancer organization, advancing a future where prostate cancer detection is early, support is unwavering, and care is accessible to all. For over 30 years, ZERO has led the way in prostate cancer advocacy, screenings, and partnerships, successfully unlocking funding toward breakthrough discoveries, treatments, and lifesaving access to care.  

As the nation’s #1 provider of prostate cancer resources, programs, and services, ZERO has supported millions of people at-risk or diagnosed, and their families. As the voice of the prostate cancer community, ZERO's urgent focus on breaking barriers to survival—by closing gaps in diagnosis, treatment, and care—brings critical attention to those most likely to be impacted by this disease.  Learn more at ZEROcancer.org